Psychiatry and Behavioral Sciences
Showing 341-360 of 1,194 Results
-
Joseph Garner
Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.
-
Marco Gassner
Graduate, Medicine, Psychiatry and Behavioral Sciences
BioMarco is a Visiting Research Scholar in the Division of Interdisciplinary Brain Sciences at the Department of Psychiatry and Behavioral Sciences, where he contributes to projects at the Mental Health Technology and Innovation Hub. His research focuses on child and adolescent mental health, with a particular interest in digital interventions.
-
Grace Gengoux, PhD, BCBA-D
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).
Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee. -
Luciana Giambarberi, MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Giambarberi is a double-board-certified physician who completed her general psychiatry training at Wake Forest University School of Medicine (2018) and her Behavioral Neurology and Neuropsychiatry (BNNP) training at Stanford University School of Medicine (2019). Her past experience includes leading, creating, expanding, and providing neuropsychiatry education and services to communities of North Carolina and other areas of the southeast region.
As a clinical associate professor in the Department of Psychiatry at Stanford, Dr. Giambarberi supervises trainees in the Neuropsychiatry Section and the Individual Psychotherapy Clinic. Dr. Giambarberi is the director of BNNP didactics, as well as neurology core rotations and elective rotations within the neuropsychiatry section.
Dr. Giambarberi has extensive experience with a diverse patient population. Her current clinical and research interests include education, epilepsy, and functional neurological disorders. -
William Giardino
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsWe aim to decipher the neural mechanisms underlying psychiatric conditions of stress, addiction, and sleep/circadian dysregulation. Our work uses combinatorial technologies for precisely mapping, monitoring, and manipulating neural circuits that regulate emotional states. We are especially focused on the behavioral functions of neuropeptide molecules acting throughout the circuitry of the extended amygdala- particularly in a brain region called the bed nucleus of the stria terminalis (BNST).
-
Erin Gibson
Assistant Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsGlia make up more than half of the cells in the human brain, but we are just beginning to understand the complex and multifactorial role glia play in health and disease. Glia are decidedly dynamic in form and function. Understanding the mechanisms underlying this dynamic nature of glia is imperative to developing novel therapeutic strategies for diseases of the nervous system that involve aberrant gliogenesis, especially related to changes in myelination.
-
Giancarlo Glick
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.
-
Ira D Glick
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
